PeploBio

PeploBio is a specialist CRO supporting pharmaceutical, biotech, and diagnostic partners in the development and clinical validation of immunological assays. We combine scientific depth with operational agility to translate biomarker research into clinically validated tools. Our expertise spans immune monitoring, microclot quantification, assay development, and regulatory support — with a track record of delivering complex studies across FDA, IVDR, and UKCA frameworks. Our Services: - Microclot Detection & Quantification – Proprietary MicroCLOTS™ assay for measuring fibrin(ogen) amyloid microclots in Long COVID, ME/CFS, cardiovascular, and thromboinflammatory conditions - Immune Monitoring – Custom flow cytometry and protein microarray panels for profiling immune dysfunction in oncology, infectious disease, and autoimmunity - Assay Development & Validation – Analytical, usability, and clinical performance studies for RUO, LDT, and regulatory submissions - Regulatory Strategy & Clinical Studies – Design and execution of studies for IVDR, FDA, and UKCA compliance. Why PeploBio? - Trusted partner to Translational Medicine teams, biotech innovators, and diagnostic manufacturers - Expertise in both discovery-stage innovation and late-stage clinical deployment - Agile team with global reach: based in London (UK), Cyprus (EU), and North Carolina (US)